PPBT
Purple Biotech
NASDAQ: PPBT · HEALTHCARE · BIOTECHNOLOGY
$4.23
-6.90% today
Updated 2026-04-29
Market cap
$6.95M
P/E ratio
—
P/S ratio
58.08x
EPS (TTM)
$-54.00
Dividend yield
—
52W range
$4 – $29
Volume
0.0M
Purple Biotech (PPBT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $311000.00 | $1.76M | $10.81M | $14.91M | $14.18M | $14.72M | $14.72M | $83.80M | $70.20M | $54.62M | $44.30M | $37.04M |
| Cash & equivalents | $193000.00 | $1.31M | $10.56M | $6.76M | $3.95M | $5.16M | $4.38M | $11.25M | $10.89M | $15.03M | $14.49M | $7.40M |
| Current assets | $311000.00 | $1.76M | $10.80M | $14.90M | $7.98M | $8.51M | $8.30M | $59.28M | $48.47M | $33.26M | $15.79M | $8.91M |
| Total liabilities | $1.26M | $986000.00 | $1.38M | $1.53M | $5.59M | $3.72M | $3.86M | $4.05M | $5.09M | $7.52M | $10.01M | $4.13M |
| Current liabilities | $1.26M | $986000.00 | $1.20M | $1.27M | $4.07M | $3.31M | $3.54M | $3.10M | $4.25M | $7.06M | $7.18M | $3.99M |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — |
| Shareholder equity | $-946000.00 | $773000.00 | $9.43M | $13.38M | $7.31M | $10.52M | $10.42M | $79.39M | $64.83M | $46.91M | $34.21M | $32.86M |
| Retained earnings | $-4.60M | $-9.85M | $-14.05M | $-26.20M | $-38.57M | $-43.67M | $-49.52M | $-77.52M | $-95.91M | $-117.58M | $-137.45M | $-144.69M |
| Accounts receivable | $38000.00 | $420000.00 | $124000.00 | $151000.00 | — | $743000.00 | $1.49M | $500000.00 | — | — | — | $275000.00 |
| Inventory | $-38000.00 | $-420000.00 | $-124000.00 | $-7.81M | — | $778000.00 | $-1.49M | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | $20.46M | $20.46M | $20.66M | $28.02M | — |